Patients with cancer have a higher risk of severe coronavirus disease (COVID-19) and
associated mortality than the general population. Owing to this increased risk, patients with …

The SARS‐CoV‐2 omicron variant (B. 1.1. 529) was first identified in Botswana and South
Africa, and its emergence has been associated with a steep increase in the number of SARS …

Understanding the impact of age on vaccinations is essential for the design and delivery of
vaccines against SARS-CoV-2. Here, we present findings from a comprehensive analysis of …

Summary Background Breakthrough SARS-CoV-2 infections following vaccination against
COVID-19 are of international concern. Patients with cancer have been observed to have …

Patients with cancer are at high risk for severe clinical courses of COVID-19 and delays of
antineoplastic treatment due to SARS-CoV-2 infections (Pinato et al., 2022). SARS-CoV-2 …

Patients with blood cancer continue to have a greater risk of inadequate immune responses
following three COVID-19 vaccine doses and risk of severe COVID-19 disease. In the …

Patients with hematologic malignancies and recipients of hematopoietic cell transplantation
(HCT) are more likely to experience severe coronavirus disease 2019 (COVID-19) and have …

The phenomenon of 'T cell exhaustion', a state of T cell dysfunction observed during chronic
infections and cancers, has been a major obstacle in mounting appropriate immune …

Current COVID-19 vaccines are based on prototypic spike sequences from ancestral 2019
SARS-CoV-2 strains. However, the ongoing pandemic is fueled by variants of concern …

Background: Patients with hematological malignancies are at greater risk of severe COVID-
19 and have been prioritized for COVID-19 vaccination. A significant proportion of them …